Prof. Dr. Hakan İsmail SARI
2018 – Present, Istanbul/Istanbul/Türkiye
MEMORIAL ATASEHIR HOSPITAL
Hematology Specialist
2006 – 2015, Denizli/Denizli/Türkiye
PAMUKKALE UNIVERSITY MEDICAL FACULTY
Hematology Specialist – Deputy Chief Physician – Quality Management Director
1998 – 2006, Kayseri/Kayseri/Türkiye
ERCIYES UNIVERSITY
Hematology Specialist – Internal Medicine Specialist
2016 – 2016
PROFESSOR
2010 – 2010
ASSOCIATE PROFESSOR
2003 – 2006, Kayseri/Türkiye
ERCIYES UNIVERSITY
Hematology Minor Specialization Training
1998 – 2003, Kayseri/Türkiye
ERCIYES UNIVERSITY
Internal Medicine Specialization Training
1990 – 1997, Ankara/Türkiye
HACETTEPE UNIVERSITY
Medical Doctor Education
Turkish Hematology Association “Young Researcher” award at the National Hematology Congress held in 2002.
Turkish Hematology Association “Clinical study” award at the National Hematology Congress held in 2003
Turkish Society of Hematology “Clinical study” award at the National Hematology Congress held in 2004
Turkish Hematology Association “Young Researcher” award at the National Hematology Congress held in 2004.
“Best Paper Award” at the 2nd Hematological Oncology Congress held in 2015
PROFESSIONAL MEMBERSHIPS
Turkish Society of Hematology
Turkish Apheresis Association
The European Hematology Association (EHA)
The European Group For Blood And Marrow Transplantation (EBMT)
Society of Hematological Oncology (SOHO)
American Society of Hematology (ASH)
Articles published in international peer-reviewed journals:
A1. Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I , Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018;57(1):27-30
A2. Hacioglu S, Karabulut A, Sari I, Keskin A. Haemostatic disorders in reproductive age women with menorrhagia and effects on quality of life. J Obstet Gynaecol. 2016;36(8):1041-1045.
A3. Dogu MH, Sari I, Hacioglu S, Degirmencioglu S, Şen N, Keskin A. Two rare diagnoses during chronic lymphocytic leukaemia follow-up: Kaposi’s sarcoma and Merkel cell carcinoma. Scott Med J 2016;61(1):60-63.
A4. Tekgündüz E, Sarı İ, Kapuağası A, Ünal D, Şencan İ, Altuntaş F. Apheresis training in Turkey. Transfus Apher Sci 2016;54(2):173-175.
A5. Cetin GO, Baris IC, Caner V, Sarikepe B, Sen Turk N, Tepeli E, Hacioglu S, Sari I, Bagci G, Keskin A. Mutational status of EZH2 and CD79B hot spots in mature B-cell non-Hodgkin’s lymphomas: novel CD79B variations have been revealed. Eur Rev Med Pharmacol Sci 2016;20(5):830-836.
A6. Tekgündüz E, Göker H, Kaynar L, Sarı İ, Pala Ç, Doğu MH, Öztürk E, Turgut B, Korkmaz S, Tetik A, Büyükaşık Y, Hacıoğlu SK, Bozdağ SC, Özdemir E, Altuntaş F. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience. Clin Lymphoma Myeloma Leuk 2016;16(5):269-274.
A7. Erkurt MA, Berber I, Tekgündüz E, Dogu MH, Korkmaz S, Demir C, Yilmaz M, Akay OM, Pala C, Bilen Y, Kaya E, Sari I, Sencan M, Kuku I, Altuntaş F, Dal MS, Aydogdu I. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study. Transfus Apher Sci. 2016;54(1):80-84.
A8. Dogu MH, Kaya AH, Berber I, Sari İ, Tekgündüz E, Erkurt MA, Iskender D, Kayıkçı Ö, Kuku I, Kaya E, Keskin A, Altuntaş F. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation? Transfus Apher Sci. 2016;54(1):76-9.
A9. Tekgündüz E, Sarı İ, Altuntaş F. Guest Editorial. Transfus Apher Sci 2016;54(1):21.
A10. Tombak A., MA Ucar, A. Akdeniz, EN Mohair, DG Sahin, OM Akay, M. Yildirim, O. Nevruz, C. Kis, E. Gurkan, SM Solmaz, MA Ozcan, R. Yıldırım, İ.Berber, MA Erkurt, TF Tuglular, P. Tarkun, I. Yavasoglu, MH Doğu, I. Sari, M. Merter, M. Ozcan, E. Yildizhan, L. Kaynar, O. Mehtap, A. Uysal, F. Sahin, O. Salim, MA Sungur. The role of azacitidine in the treatment of elderly patients with AML-results of a retrospective multicenter study. Turk J Hematol. Ahead of Print: TJH-55632 | DOI: 10.4274/tjh.2015.0203
A11. Hacıoğlu S.K., M.H. Doğu, İ. Sarı, A. Keskin. Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia. Balkan Med J 2015;32(2):218-20.
A12. Sahin F., M.C. Ozkan, N.G. Mete, M. Yilmaz, N. Oruc, A. Gurgun, M. Kayikcioglu, A. Guler, F. Gokcay, F. Bilgir, C. Ceylan, O. Bilgir, I.H. Sari, Saydam G. Multidisciplinary clinical management of paroxysmal nocturnal hemoglobinuria. Am J Blood Res, 5(1):1-9 (2015).
A1 Caner V., N. Sen Turk, IC Baris, GO Cetin, E. Tepeli, S. Hacioglu, I. Sari, S. Zencir, MH Dogu, G. Bagci, A. Keskin. MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas. Gene Test Mol Biomarkers, 19(7):372-8 (2015)
A14. Barış İ.C., V. Caner, N. Şen Türk, İ. Sarı, S. Hacıoğlu, MH Doğu, O. Çetin, E. Tepeli, Ö. Can, G. Bagci, A. Keskin. Possible Role of GADD45g Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement? Turk J Haematol, Apr 27 (2015). doi: 10.4274/tjh.2014.0174. [Epub ahead of print]
A15. Erdoğan C., I. Sarı, H. Herken, E. Değirmenci, A. Oğuzhanoğlu. Remarkable effect of benzodiazepine in a patient with anti-NMDA receptor encephalitis. Acta Neurol Document, 114(3):233-4 (2014).
A16. Hacioğlu S., I. Sarı, M.H. Doğu, A. Keskin. The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF. Transfus Apher Sci 2014;50(1):71-4.
A17. Korkmaz S., M. Keklik, S. Sivgin, R. Yildirim, A. Tombak, M.E. Kaya, D.Y. Acik, R. Esen, S.K. Hacioglu, M. Sencan, I. Kiki, E.N. Tiftik, I. Kuku, V. Okan, M. Yilmaz, C. Demir, I. Sari, F. Altuntas, A. Unal, O. Ilhan. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci, 48(3):353-8 (2013).
A18. Ergin C., M. Kutlu, SA Akdağlı, Z. Sarıbaş, FA Ozansoy, I. Sarı, N. Dursunoğlu. Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient. Find Microbiol 2013;47(2):351-5.
A19. Tekgündüz E., F Altuntaş, S Sıvgın, SZ AKI, A. Dönmez, P. Topçuoğlu, R. Yıldırım, NA Baysal, E. Ayyıldız, MK Yüksel, I. Sarı, M. Tombuloğlu, A. Unal, O. Ilhan . Plerixafor use in patients with previous mobilization failure: A multicenter experience. Transfus Apher Sci, 47(1):77-80 (2012).
A20. Sari I., Arslan A, Ozlu C, Hacioglu S, Dogu MH, Isler K, Keskin A. The effect of pneumatic tube system on complete blood count parameters and thrombocyte donation in healthy donors. Transfus Apher Sci, 47(1):81-3 (2012).
A21. Balci Y.I., A. Karabulut, S. Kabukcu, I. Sari, A. Keskin. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia. Clin Appl Thromb Hemost, 17(4):320-2 (2011).
A22. Sari I, I. Turkcuer, T. Erurker, M. Serinken, M. Seyit, A. Keskin. Therapeutic plasma exchange in amitriptyline intoxication: case report and review of the literature. Transfus Apher Sci, 45(2):183-5 (2011)
A23. Kiter G., Y.I. Balci, A. Ates, S. Hacioglu, I. Sari. Frequency of pulmonary hypertension in asymptomatic β-thalassemia major patients and the role of physiological parameters in evaluation. Pediatr Hematol Oncol, 27(8):597-607 (2010).
A24. Kelten C., M. Akbulut, B. Ege, S. Kabukcu, I. Sari, E. Duzcan. Bilateral breast involvement in multiple myeloma: a diagnostic pitfall in terms of plasmacytoid cytomorphology in breast aspiration cytology. Diagn Cytopathol,38(12):936-8 (2010).
A25. Sari I., M.A. Erkurt, A. Ifran, K. Kaptan, C. Beyan. Multiple myeloma presenting with acquired factor VIII inhibitor. Int J Hematol. 2009;90(2):166-9.
A26. Hacioglu, S., F. Altuntas, L. Kaynar, I. Sari, T. Patiroglu, M. Cetin, “Rhabdomyolysis in a Healthy Peripheral Blood Stem Cell Donor Following Mobilization with Filgrastim,” Transfus Med Hemother, 36(2):135-137 (2009).
A27. Turkcuer, I., B. Erdur, I. Sari, A. Yuksel, P. Tura, S. Yuksel, “Severe metformin intoxication treated with prolonged haemodialyses and plasma Exchange,”
Eur J Emerg Med, 16(1), 11-13 (2009).
A28. Cetin, A., L. Kaynar, I. Kocyigit, S.K. Hacioglu, R. Saraymen, A. Ozturk, I. Sari, O. Sagdic, “Role of grape seed extract on methotrexate induced oxidative stress in rat liver,” Am J Chin Med, 36(5), 861-872 (2008).
A29. Altuntas, F., I. Sari, I. Kocyigit, L. Kaynar, S. Hacioglu, A. Ozturk, M. Oztekin, M. Solmaz, B. Eser, M. Cetin, A. Unal, “Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators,” Transfus Med Hemother, 35(5), 368-373 (2008).
A30. Sari, I., I. Kocyigit, F. Altuntas, L. Kaynar, B. Eser, “An unusual case of acute brucellosis presenting with Coombs-positive autoimmune hemolytic anemia,” Intern Med, 47(11), 1043-1045 (2008).
A31. Sari, I., A. Cetin, L. Kaynar, R. Saraymen, S.K. Hacioglu, A. Ozturk, I. Kocyigit, F. Altuntas, B. Eser, “Disturbance of pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation,” Ann Clin Lab Sci, 38(2), 120-125 (2008).
A32. Erkurt, M.A., I. Sari, H.C. Gül, O. Coskun, CP. Eyigun, C. Beyan, “The first documented case of brucellosis manifested with pancytopenia and capillary leak syndrome,” Intern Med 47(9), 863-865 (2008).
A33. Kaynar, L., F. Altuntas, I. Aydogdu, B. Turgut, I. Kocyigit, S.K. Hacioglu, S. Ismailogullari, N. Turgut, MA. Erkurt, I. Sari, M. Oztekin, M. Solmaz, B. Eser, AO. Ersoy, A. Unal, M. Cetin, “Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study,” Transfus Apher Sci, 38(2), 109-115 (2008).
A34. Sari, I., F. Altuntas, S. Hacioglu, I. Kocyigit, A. Sevinc, S. Sacar, K. Deniz, E. Alp, B. Eser, O. Yildiz, L. Kaynar, A. Unal, M. Cetin, “A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis,” Am J Hematol, 83(4), 334-339 (2008).
A35. Sav, T., B. Tokgoz, MH. Sipahioglu, M. Deveci, I. Sari, O. Oymak, C. Utas, “Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?” Ren Fail, 29(4), 423-426 (2007).
A36. Altuntas, F., I. Kocyigit, A. Ozturk, L. Kaynar, I. Sarı, M. Oztekin, M. Solmaz, B. Eser, M. Cetin, A. Unal, “Comparison of the Fenwal Amicus and Fresenius Com.tec cell separators for autologous peripheral blood progenitor cell collection,” Transfus Apher Sci, 36(2), 159-167 (2007).
A37. Altuntas, F., İ. Aydogdu, S. Kabukcu, İ. Kocyigit, K. Cikim, I. Sari, M. Ali Erkut, B. Eser, A. Ozturk, E. Kaya, M. Cetin , A. Keskin , A. Unal, “Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study,” Transfus Apher Sci, 36(1), 57-67 (2007).
A38. Sari, I., F.Altuntas, İ.Kocyigit, Y.Sisman, B.Eser, A.Unal, T.Fen, A.Ferahbas, A.Ozturk, A.Unal, M.Cetin, ”The effect of budesonide mouthwash on oral chronic graft versus host disease,” Am J Hematol, 82(5), 349-356 (2006).
A39. Alp, E., O. Yildiz, B. Aygen, B. Sumerkan, I. Sari, K. Koc, A. Couble, F. Laurent, P. Boiron, M. Doganay, “Disseminated nocardiosis due to unusual species: two case reports,” Scand J Infect Dis, 38(6-7), 545-548 (2006).
A40. Eser, B., I.Sari, Ö.Canöz, F.Altuntas, E.Cakmak, A.Ozturk, M.Ozkan, Ö.Er, M.Cetin, A.Unal, “Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma,” Am J Hematol, 81(5), 307–314 (2006)
A41. Ozkan M., B. Eser, O. Er, H. Senol Coskun, A. Ozturk, I. Sari, O. Canoz, M. Altinbas, “Bone marrow involvement in small cell lung cancer: Prognostic significance and correlation with hematological and biochemical parameters”, Asia-Pasific Journal of Clinical Oncology, 2, 31-37 (2006).
A42. Altuntaş, F., I. Sarı, Ö. Canoz, B. Eser, O. Yıldız, M. Çetin, A. Ünal, “Kikuchi-Fujimoto disease: a rare but important cause of fever and lymphadenopathy in pregnant women,” Am J Hematol, 81(2), 118–120 (2006).
A43. Eser B., B.Kaplan, A.Unal, Ö.Canoz, F.Altuntaş, HI.Sarı, M.Cetin, “Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s Iymphomas in Central Anatolia, in Turkey”. Yonsei Medical Journal, 47(1), 22-33 (2006).
A44. Cetin, M., S. Buyukberber, M. Demir, I. Sari, , K. Deniz, B. Eser, F. Altuntas, C. Camci, A. Ozturk, B.Turgut, O.Vural, A.Unal, “Overexpression of Cyclooxygenase-2 in Multiple Myeloma: Associated with Reduced Survival,” Am J Hematol, 80(3), 169-173 (2005)
A45. Unal, A., I. Sari, K. Deniz, M. Ozkan, O. Kontas, B. Eser, M. Cetin, “Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab,” Leuk Lymphoma, 46(2004) . 11), 1613–1617 (2005).
A46. Altuntas, F., O. Yildiz, I. Sari, B. Eser, M. Cetin, A. Unal, “Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura,” Am J Haematol, 80, 204-205 (2005)
A47. Eser, B., M. Guven, A. Unal, R. Coskun, F. Altuntas, M. Sungur, IS. Serin, I. Sari, M. Cetin, “The Role of Plasma Exchange in HELLP Syndrome,” Clin Appl Thromb Hemost, 11(2), 211-217 (2005).
A48. Altuntas, F., O. Yıldız, B. Eser, I. Sarı, M. Cetin, A. Unal, “Severe Thrombotic Microangiopathy Associated with Brucellosis: Successful Treatment with Plasmapheresis,” Clin Appl Thromb Hemost, 11(1),105-108 (2005).
A49. Guven, M., M. Sungur, B. Eser, I. Sari, F. Altuntas, “The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning,” J Toxicol Clin Toxicol, 42(5), 617-623 (2004).
A50. Tokgoz, B., HI Sari, O. Yildiz, S. Aslan, M. Sipahioglu, T. Okten, O. Oymak, C. Utas, “Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients,” Transplant Proc, 36(9), 2699-2702 (2004).
B. Papers presented at international scientific meetings and published in the proceedings book:
B1. Korkmaz S., M. Keklik, S. Sivgin, R. Yildirim, A. Tombak, M. Emin Kaya, D. Yanardag Acik, R. Esen, S. Kabukcu, M. Sencan, I. Kiki, E.N. Tiftik, I. Kuku, V. Okan, M. Yilmaz, C. Demir, I. Sari, F. Altuntas, A. Unal, O. Ilhan. 14th International Congress of the World Apheresis Society and 7th National Congress of Turkish Society of Apheresis abstractlarından, ‘Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study’, abstract no:O-09, 5 pp., Istanbul, Turkey, September 13-15, 2012.
B2. Goker H., E. Tekgunduz, I. Sari, C. Pala, M.H. Dogu, E. Ozturk, B. Turgut, S. Korkmaz, I. S. Demiriz, Y. Buyukasik, S.K. Hacioglu, L. Kaynar, S. Civriz Bozdag, F. Altuntas. Philedelphia-positive acute lymphoblastic leukemia in daily practice: A multicenter experience. Journal of Clinical Oncology, 2013 ASCO Annual Meeting Abstracts. Vol 31, No 15 suppl (May 20 Supplement), 2013:e18014.
B3. Sari I, M.H. Dogu, S. Hacioglu, S. Erturk, I.H. Akbudak, A. Keskin. The comparison of peripheral and central venous Access in terms of stem cell kinetics for peripheral blood stem cell mobilization. American Society of Apheresis 35th Annual Meeting, San Francisco, California, April 2-5, 2014.
B4. Hacioglu S., I. Sari, M.H. Dogu, S. Erturk, I.H. Akbudak, A. Keskin. Changes in serologic markers of hepatitis B in autologous hematopoietic stem cell transplantation recipients. American Society of Apheresis 35th Annual Meeting, San Francisco, California, April 2-5, 2014.
B5. Tombak A., N. Tiftik, M.H. Dogu, I. Sari, M.O. Akay, M. Karagulle, E. Kaya, S. Korkmaz, M. Sencan, G. Akyol, L. Kaynar, M. Comert, G. Saydam, S.M. Dal, O.M. Ayyildiz, R. Yildirim, I. Kiki, E. Kara, R. Esen, M.A. Sungur, M.A. Erkurt, F. Altuntas, A. Unal, Osman Ilhan. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study. 56th ASH Annual Meeting, San Francisco, California, 6-9 December, 2014.
B6. Dogu M.H., M. Keklik, H. Terzi, S. Korkmaz, M.A. Erkurt, G.A. Cagliyan, L. Kaynar, S. Sivgin, I. Sarı, A. Keskin, M. Sencan, F. Altuntas, O. Ilhan. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes. SOHO 2014 Annual Meeting, Houston, Texas, September 17-20, 2014.
B7. Sari I., M.H. Dogu, S. Hacioglu, A. Keskin. The role of hemoglobin and ferritin levels in differential diagnosis at patients with MDS-refractory anemia of chronic disease. P200. 7th Biennial International Congress on Myeloproliferative Neoplasms and Myelodysplasia, New york, America, 7-8 November, 2013.
B8. Sari I., S. Korkmaz, M. Sencan,I. Kiki,E.N. Tiftik, H. Kaya, C. Demir, A. Unal, F. Altuntas, O. Ilhan. 13th Meeting Of The International Society of Geriatric Oncology kongresi bildiri kitapçığında abstract ‘The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study’, abstract no:P077, 558 pp., Copenhagen, Denmark, October 2013.
B9. S. Korkmaz, M. Keklik, S. Sivgin, R. Yildirim, A. Tombak, M. Emin Kaya, D. Yanardag Acik, R. Esen, S. Kabukcu, M. Sencan, I. Kiki, E.N. Tiftik, I. Kuku, V. Okan, M. Yilmaz, C. Demir, I. Sari, F. Altuntas, A. Unal, O. Ilhan. 14th International Congress of the World Apheresis Society and 7th National Congress of Turkish Society of Apheresis abstractlarından, ‘Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study’, abstract no:O-09, 5 pp., Istanbul, Turkey, September 13-15, 2012.
B10. Sari, I., M.A. Erkut, A.Irfan, K. Kaptan, C. Beyan, “Multiple myeloma presented with acquired factor VIII inhibitor,” Haematologica-The Hematology Journal, 93 (suppl 1), 473-474, 2008.
B11. Sari, I., A. Cetin, L. Kaynar, R. Saraymen, S. Kabukcu Hacioglu, A. Ozturk, I. Kocyigit, F. Altuntas, B. Eser, “Disturbance of the pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation,” Haematologıca-The Hematology Journal, 93 (suppl 1), 535, 2008.
B12. Altuntas, F., I. Kocyigit, L. Kaynar, I. Sari, S. Kabukcu, M. Sekercan, OG. Yıldız, Canoz O, Eser B, Sencan M, Gülec M, Unal A, Cetin M, “Autologous peripheral blood stem cell transplantation in patients with relapsed non-hodgkin lymphoma: Cappadocia BMT center experience,” Bone marrow Transplantation, 39 (suppl 1 ), 318, 2007.
B13. Keskin, A., SK. Hacioglu, I. Sari, B. Yapar, N. Sen, S. Karti, “Standart and dose modified ARA-C/Idarubicin Remission Induction Therapy in Elderly De-novo Acute Myeloid Leukemia Patients: A retrospective Analysis from “Denizli Leukemia-Lymphoma Study Group” (DLSG),” Turkish Journal of Hematology, 24 (suppl 1), 112, 2007.
B14. Hacioglu, S.K., I. Sari , S. Karti , S. Yuksel , N. Sen , A. Keskin. Clinicopatologic Features And Treatment Results Of Non-Hodgkin Lymphomas İn Elderly Patients: A Retrospective Analysis From “Denizli Leukemia-Lymphoma-Myeloma Study Group” (DLLMSG),” Turkish Journal of Hematology, 24 (suppl 1), 122, 2007.
B15. Hacioglu, S.K., I. Sari, S. Karti, N. Sen, B. Dursun, A. Keskin. Clinical and Biochemical Features for Monitoring Multiple Myeloma: A retrospective Analysis from “Denizli Leukemia-Lymphoma-Myeloma Study Group” (DLLMSG),” Turkish Journal of Hematology, 24 (suppl 1), 132, 2007.
B16. Sari, I., F. Altuntas, I. Kocyigit, Y. Sisman, B. Eser, A. Unal, T. Fen, A. Ferhabas, A. Oztürk, A. Unal, M. Cetin, “Budesonide mouthwash therapy: a safe and effective protocol for oral chronic graft-versus-host disease,” Bone marrow Transplantation, 37 (suppl 1), 421, 2006.
B17. Cetin, M., I. Sarı, F. Altuntas, O. Yildiz, N. Koc, H. Mavus Buldu, I. Kocyigit, B. Eser, A. Unal, “Invazive fungal infections in allogeneic haematopoietic stem cell transplantation: the six-years experience of a Cappodoccia transplant center, Turkey,” Bone marrow Transplantation, 37 (suppl 1), 727, 2006.
B18. Sari, I., F. Altuntas, A. Unal, B. Eser, M. Borlu, A. Ferahbas, M. Cetin, A. Unal, “Dermatomyositis after allogeneic stem cell transplantation as sole manifestation of acute graft versus host disease,” Turkish Journal Hematology, 22 (suppl), 704, 2005.
B19. Yildiz, O., F. Altuntas, I. Sari, O. Coban, B. Eser, A. Unal, A. Unal, M.Cetin, “Microbiological findings of early infection in allogeneic or otolog stem cell transplantation,” Bone Marrow Transplantation, 35 (suppl 2), 1147, 2005.
B20. Cetin, M., I. Sari, O. Coban, B. Eser, F. Altuntas, A. Unal, O. Canoz, E. Mavili, O. Orhan, B. Kaplan, A. Unal, “Comparison of different conditioning regimens used in relapse agressive non-Hodgkin lymphoma: ICE- CNV-BEAM,” Bone Marrow Transplantation, 35 (suppl 2), 1249, 2005.
B21. Sari, I., B. Eser, M. Kula, F. Altuntas, E. Mavili, M. Ozkan, M. Cetin, A. Tutus, A. Ünal, “GA-67 Uptake, A Predictor of Active Minimaly Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma,” The Hematology Journal, 5 (suppl. 2), 334, 2004.
B22. Cetin, M., F. Altuntas, I. Sari, B. Eser, O. Er, O. Canoz, B. Kaplan, M. Ozkan, E. Albayrak, S. Bahar, Y. Ozkul, T. Patiroglu, A. Unal, “Nonmyeloablative stem cell transplantation for the treatment of hematologic malignancies and metastatic solid tumors: a single-center experience,” Bone Marrow Transplantation; 33 (suppl 1), 328, 2004.
C1. Written national/international books:
C1.1. Hodgkin Lymphoma Treatment, Scientific Medicine Publishing House, Ankara, 2012, ISBN: 978-605-4488-24-7.
C1.2. Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphomas, Scientific Medicine Publishing House, Ankara, 2012, ISBN: 978-605-4488-25-4.
D. Articles published in national peer-reviewed journals:
D1. East MH, I. Sari, S. Erturk, S. Hacioglu, A. Keskin. Apheresis platelet donation: Demographic findings, procedure and product characteristics. Pam Medical Journal, 8(1):19-22 (2015).
D2. East MH, I. Yellow. Use of Hemostatic Agents in Hemorrhagic Diathesis. Turkiye Klinikleri J Hematol-Special Topics, 8(2):82-4. (2015)
D3. Doğu MH, S. Hacıoğlu, İ. Yellow, A. Keskin. Could eltrombopag, a drug used in the treatment of immune thrombocytopenia, be the cause of pseudothrombocytopenia? Case report. Pam Medical Journal, 7(1):83-85 (2014)
D4. Doğu M.H., I. Sari, S. Hacioglu, A. Keskin. Dramatic response in the dependency to transfusion after low doses of lenalidomide treatment in a 5q-syndrome patient: a case report. North Clin Istanbul,1(3):191-193 (2014).
D5. Kutlu SS, D. Ökke, M. Demir, E. Tepeli, İ. Yellow. Penicillin Susceptibility in Viridans Group Streptococci Isolated from Oropharynx of Patients with Hematological Cancer. Klimik Magazine, 25(1):6-9 (2012)
D6. East MH, I. Yellow. New Treatment Alternatives. Turkiye Klinikleri J Hem Onc-Special Topics, 5(3):66-74 (2012)
D7. East MH, I. Yellow. Diagnosis of Hemolytic Anemias and Correct Use of Laboratory Methods. Turkiye Klinikleri J Hem Onc-Special Topics, 5(4):48-51 (2012).
D8. Sarı, İ., M. Kula, B. Eser, L. Kaynar, F. Altuntaş, İ. Koçyiğit, E. Mavili, A. Tutuş, M. Çetin, A. Ünal, “Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma”, Erciyes Medical Journal, 30 (1), 8-13 (2008).
D9. Sari, I., L. Kaynar, İ. Koçyiğit, F. Altuntas, “The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe?”, Turk J Hematol, 25, 205-206 (2008).
D10. A. Keskin, I. Yellow Hairy Cell Leukemia. Turkiye Klinikleri J Int Med Sci, 3 (19):55-61 (2007).
D11. Sarı, İ., A. Aybal, B. Eser, A. Ünal, F. Altuntaş, A. Ünal, M. Cetin, “Horner syndrome due to jugular central venous catheterization: A case report” Erciyes Medical Journal, 28 (4) , 230–232 (2006).
D12. Deniz, K., I. Sari, E. Torun, TE. Patıroglu, “Localized amyloidosis of the stomach associated with vitamin B12 defficiency”, The Turkish Journal of Gastroenterology, 17 (2), 116-9 (2006).
D13. Ferahbaş, A., Y. Ulaş, S. Utaş, B. Eser, Ö. Canoz, I. Sarı, O. Kontaş, M. Çetin, A. Ünal, “Primary cutaneous lymphoma: Retrospective evaluation”, Erciyes Medical Journal, 28 (2), 77-81 (2006).
D14. Sarı, İ., OY. Coban, M. Ozkan, B. Eser, A. Unal, T. Sav, M. Cetin, “Malignancy-related thrombotic thrombocytopenic purpura: 2 Case Reports”, Erciyes Medical Journal, 27 (4), 180-183 (2005).
D15. Altuntas, F., O. Yildiz, B. Eser, E. Alp, I. Sari, M. Cetin, B. Sumerkan, A. Unal, “Microbiologically documented infections following peripheral blood stem cell transplantation: Single center experience”, Turkish J Hematol, 22 (3),133–145 (2005).
D16. A. Unal, I. Sarı, “Stem Cell Apheresis”, Turkiye Klinikleri J Int Med Sci, 1 (19), 58-63 (2005).
D17. F. Altuntaş, L. Kaynar, B. Eser, İ. Sarı, B. Kaplan, M. Özkan, M. Çetin, A. Ünal, “Comparison of three different conventional chemotherapy protocols in the treatment of multiple myeloma: Single center experience”, Turkish Journal of Oncology, 19 (1), 9–14, 2004.
D18. WHAT. Sarı, B. Aygen, O. Yıldız, D. Eşel, “Spleen abscess due to Streptococcus Intermedius: A Case Report. Journal of Infection Turkish Journal of Infection, 17 (3), 349-351 (2003).
E. Papers presented at national scientific meetings and published in proceedings books:
E1. East MH, I. Sari, S. Hacioglu, A. Keskin. Visual Analogue Scale (VAS) in Pain Allocation in Multiple Myeloma Patients. 2. Hematological Oncology and Bone Marrow Transplantation Symposium, 05-08 February 2015, TRNC.
E2. Erkurt MA, I. Berber, MH Doğu, S. Korkmaz, C. Demir, M. Yılmaz, OM Akay, Ç. Pala, Y. Bilen, I. Kuku, I. Sarı, M. Şencan, E. Kaya, F. Altuntaş, O. İlhan. Clinicopathological Features and Treatment Outcomes of Primary Central Nervous System Lymphoma: A Multicenter Retrospective Study. 2. Hematological Oncology and Bone Marrow Transplantation Symposium, 05-08 February 2015, TRNC.
E3. I. Aydoğdu, D. Soyer, M. Yeral, S. Solmaz, M. Maden, GE Pamuk, O. Salim, M. Yılmaz, V. Karakuş, MH Doğu, Ü. Malkan, DG Şahin, E. Kelkitli, MH Atay, G. Akyol, MS Dal, GA Çağlıyan, A. Karakuş, H. Terzi, İ. Berber, M. Miskioglu, S. Korkmaz, H.I. Sarı, B. Eser, F. Altuntaş. Clinical Features and Treatment Results in Extramedullary Myeloid Leukemia; Türkiye Data. 2nd Hematological Oncology Congress, 09-13 September 2015, TRNC.
E4. Gemici A.I., I. Aydoğdu, H. Terzi, M. Şencan, AH Kaya, MS Dal, MO Akay, MH Doğu, O. Ayyıldız, F. Şahin, GE Pamuk, GA Çağlayan, M. Yılmaz, Z. Gökgöz, Y. Bilen, C. Demir, S. Korkmaz, H.I. Sarı, B. Eser, F. Altuntaş. Nodular lymphocyte-predominant hodgkin lymphoma: data from Türkiye. 2nd Hematological Oncology Congress, 09-13 September 2015, TRNC.
E5. Açıkgöz GS, İ. Sarı, K. İlkkılıç, MH Doğu, S. Hacıoğlu, A. Keskin. Bevacizumab treatment in hereditary hemorrhagic telangiectasia: two case reports. 2nd Hematological Oncology Congress, 09-13 September 2015, TRNC.
E6. Kızılırmak Ö., İ. Sarı, MH Doğu, S. Hacıoğlu, A. Keskin. Refractory autoimmune hemolytic anemia as a fatal disease: a case report. 2nd Hematological Oncology Congress, 09-13 September 2015, TRNC.
E7. Oguz K., I. Sarı, K. İlkkılıç, MH Doğu, S. Hacıoğlu, A. Keskin. The effect of chemotherapy + growth factor use on stem cell product and mobilization success in autologous peripheral stem cell mobilization in elderly patients with multiple myeloma. 2nd Hematological Oncology Congress, 09-13 September 2015, TRNC.
E8. Doğu MH, S. Hacıoğlu, İ. Yellow, A. Keskin. Exaggerated response to eltrombopag therapy and dose adjustment in a patient with refractory immune thrombocytopenia. 39. National Hematology Congress, 23-26 October 2013, Antalya.
E9. Doğu H., S. Hacıoğlu, İ. Sari, S. Erturk, A. Keskin. The Importance of Peripheral Smear in a Patient Diagnosed with Refractory Immune Thrombocytopenia. 39. National Hematology Congress, 23-26 October 2013, Antalya.
E10. Doğu H., S. Hacıoğlu, İ. Yellow, A. Keskin. Use of low-dose clofarabine / ARA-C in patients with fludarabine-refractory acute leukemia: A Single Center Experience. 39. National Hematology Congress, 23-26 October 2013, Antalya.
E11. Caglayan AG, I. Yellow, L.S. Tufan, A. Keskin. Relationship between JAK2V617F mutation and bleeding, thrombosis and platelet functions in myeloproliferative neoplasms. 36. National Hematology Congress, 3-7 November 2010, Belek, Antalya.
E12. Yuksel S.C., I. Yellow, A. Keskin. Clinical-pathological features and treatment results of our patients with non-Hodgkin lymphoma. 36. National Hematology Congress, 3-7 November 2010, Belek, Antalya.
E13. Hacioglu SK, I. Sari, A. Keskin. Investigation of von Wilebrand disease and platelet dysfunction in patients with menorrhagia. 36. National Hematology Congress, 3-7 November 2010, Belek, Antalya.
E14. Hacioglu, SK, I. Sarı, A. Keskin, E. Düzcan, “Subacute panniculitis-like T-cell lymphoma (SPTCL) case with diffuse sea blue histiocytes in the bone marrow”, XXXIV. National Hematology Congress, P0167, Çeşme-İzmir, 2008.
E15. Kaynar, L., F. Altuntaş, I. Aydogdu, B. Turgut, I. Koçyiğit, SK Hacıoğlu, A. Özdemir Ersoy, MA Erkurt, N. Turgut, İ. Sarı, M. Öztekin, M. Solmaz, B. Eser, A. Ünal, M. Çetin, “Therapeutic Plasma Exchange in Neurological Diseases: A Retrospective Multicenter Study”, Turkish Hematology Society 33rd National Congress, S0064, Ankara, 2007.
E16. Çobankara, V., S. Şenel, S. Hacıoğlu, İ. Sarı, “Hereditary Hemorrhagic Telangiectasia (Osler-Weber Rendu Syndrome) and Ankylosing Spondylitis Case Report”, Rheumatology 2007 Congress Congress Book, p:116-117, Ölüdeniz-Fethiye, 2007.
E17. Sarı, İ., F. Altuntaş, SK Hacıoğlu, İ. Koçyiğit, A. Sevinç, S. Saçar, K. Deniz, E. Alp, B. Eser, O. Yıldız, L. Kaynar, A. Ünal, M. Çetin, “Hematological and clinical findings in brucellosis cases with pancytopenia: Very based retrospective study”, XXXII. National Hematology Congress, Verbal 03, Antalya, 2006.
E18. Kabukcu, S., F. Altuntaş, I. Koçyiğit, L. Kaynar, İ. Sarı, M. Sipahioglu, B. Eser, O. Yıldız, S. Gökahmetoğlu, K. Erkılıç, F. Tanrıverdi, M. Güleç, A. Ünal, M. Çetin, “Late side effects after allogeneic hematopoietic stem cell transplantation: Cappadocia transplant center experience”, XXXII. National Hematology Congress, Verbal 89, Antalya, 2006.
E19. Cetin, M., F. Altuntas, L. Kaynar, I. Koçyiğit, İ. Sari, A. Yurci, O. Canöz, B. Eser, S. Kabukcu, A. Ferahbaş, A. Ünal. “Graft versus host disease: Cappadocia transplant center experience”, XXXII. National Hematology Congress, Poster 144, Antalya, 2006.
E20. Altuntas, F., L. Kaynar, I. Sarı, O. Yıldız, B. Eser, M. Öztekin, M. Solmaz, M. Çetin, M. Sungur, M. Güven, A. Ünal, “The effect of therapeutic plasma exchange on hemodynamic parameters in sepsis: A pilot study”, XXXII. National Hematology Congress, Sözel 45, Antalya, 2006.
E21. Dogruel, F., I. Yellow, I. Koçyiğit, S. Kabukcu, L. Kaynar, F. Altuntaş, B. Eser, M. Çetin, A. Ünal, “Comparison of EMA and FLAG rescue regimens used in relapsed or refractory acute myeloid leukemia”, XXXII. National Hematology Congress, Poster 112, Antalya, 2006.
E22. Altuntas, F., I. Koçyiğit, L. Kaynar, A. Öztürk, İ. Sarı, B. Eser, M. Öztekin, M. Solmaz, A. Ünal, M. Çetin, “Comparison of Fenwal Amikus and Fresenius COM.TEC apheresis machines in autologous peripheral blood stem cell collection”, XXXII. National Hematology Congress, Poster 322, Antalya, 2006.
E23. Ozkan, M., I. Yellow, I. Kocyigit, O. Er, B. Eser, Y. Özkul, GG. Doğu, M. Altınbaş, “Thrombosis in Cancer Patients”, XVI. National Cancer Congress, Ref 139, Kemer-Antalya, 2005.
E24. Altuntaş, F., B. Eser, İ. Sarı, M. Çetin, Y. Özkul, A. Ünal, “Effects of rituximab monoclonal antibody therapy on clinical and molecular response in relapsed/refractory low-grade B-cell non-Hodgkin lymphomas”, I. National Medical Oncology Congress, B3, Kemer- Antalya, 2004.
E25. Altuntas, F., I. Sarı, B. Eser, M. Ozkan, Ö. Er, M. Cetin, A. Ünal, “Two different bisphosphonate treatments in multiple myeloma: Comparison of pamidronate and zoledronic acid”, I. National Medical Oncology Congress, B19, Kemer-Antalya, 2004.
E26. Sarı, İ., F. Altuntaş, M. Sipahioğlu, B. Eser, T. Sav, M. Çetin, A. Ünal, “Acyclovir-induced severe neurotoxicity and nephrotoxicity: A case report”, I. National Medical Oncology Congress, B. 35, Antalya, 2004.
E27. Cetin, M., S. Büyükberber, M. Demir, İ. Yellow, I. Sarı, K. Deniz, B. Eser, F. Altuntaş, C. Camcı, A. Ozturk, B. Turgut, Ö. Vural, A Unal, “The relationship of cyclooxygenase expression with prognosis and survival in Multiple Myeloma”, XXXI. National Hematology Congress, Proceeding 59, Belek-Antalya, 2004.
E28. Cetin, A., I. Sarı, S. Muhtaroğlu, D. Çabuk, S. Kuzugüden, B. Eser, M. Özkan, “Decreased adenosine deaminase activity and increased oxidative stress in oncology nurses exposed to antineoplastic drugs”, XXXI. National Hematology Congress, Poster 48, Belek-Antalya, 2004.
E29. Ferahbaş, A., B. Eser, Ö. Canöz, Y. Ulaş, İ. Sarı, O. Kontaş, S. Utaş, M. Çetin, “Primary cutaneous lymphoma: Retrospective evaluation”, XXXI. National Hematology Congress, Paper 14, Belek-Antalya, 2004.
E30. Sarı, İ., Ö. Shepherd, B. Eser, F. Altuntaş, Y. Özkul, M. Özkan, Ö. Er, M. Çetin and A. Ünal, “7/3 ARA-C/IDA chemotherapy protocol in de-novo acute myeloblastic leukemia cases, Erciyes University, Dedeman Hospital experience”, XXXI. National Hematology Congress, Poster 102, Antalya, 2004.
E31. Cetin, M., I. Sarı, B. Eser, F. Altuntaş, Y. Özkul, H. Beyazal, M. Özkan, Ö. Er, A. Unal. “EMA + cyclosporine chemotherapy regimen in patients with primary refractory or relapsed acute myeloblastic leukemia”, XXXI. National Hematology Congress, Poster 116, Antalya, 2004.
E32. Eser, B., İ. Yellow, O. Canöz, F. Altuntaş, E. Cakmak, M. Özkan, Ö. Er, M. Çetin, A. Ünal, “Clinical significance of Fas expression in diffuse large B-cell non-Hodgkin lymphoma”, XXXI. National Hematology Congress, Proceeding 15, Belek-Antalya, 2004.
E33. Unal, A., I. Sarı, B. Kaplan, B. Eser, F. Altuntaş, O. Kontaş, M. Özkan, K. Deniz, M. Çetin, “Familial nodular lymphocyte predominant Hodgkin lymphoma, successful treatment with CHOP+rituximab”, XXXI. National Hematology Congress, Poster 231, Belek-Antalya, 2004.
E34. Sarı, İ., Özlem Çoban, B. Eser, F. Altuntaş, Y. Özkul, M. Özkan, Ö. Er, M. Çetin and A. Ünal, “Intensive dose phase results of HYPER-CVAD regimen in adult acute lymphoblastic leukemia cases: Erciyes University, Dedeman Hospital Experience”, XXXI. National Hematology Congress, Poster 99, Kemer-Antalya, 2004.
E35. M. Cetin, I. Sari, M. Ozocak, O. Canöz, K. Deniz, O. Kontaş, E. Mavili, A. Öztürk, A. Ünal, “Primary extranodal head and neck lymphomas: Erciyes University, Dedeman Hospital Experience”, XXXI. National Hematology Congress, Poster 143, Belek-Antalya, 2004.
E36. Altuntas, F., A. Aybal, I. Sarı, B. Eser, M. Güven, M. Çetin, M. Sungur, A. Unal, “Do intensive care units contribute to reducing mortality in hematological diseases?: Single center experience”, XXXI. National Hematology Congress, Poster 275, Belek- Antalya, 2004.
E37. Sarı, İ., G. İlbeyli, O. Yıldız, A. Köşklükuru, B. Eser, F. Altuntaş, M. Çetin, A. Ünal, “Classical amphotericin B in febrile neutropenia: Erciyes University, Dedeman Hospital Experience”, XXXI. National Hematology Congress, Poster 287, Belek-Antalya, 2004.
E38. Sarı, İ., A. Kösklukuru, O. Yıldız, B. Eser, F. Altuntaş, M. Özkan, Ö. Er, M. Çetin, A. Ünal, “Comparison of cefepime+amikasin combination with meropenem+amikasin combination in febrile neutropenic patients”, XXXI. National Hematology Congress, Poster 314, Belek-Antalya, 2004.
E39. Unal, A., I. Sarı, M. Özocak, B. Eser, F. Altuntaş, İ.S. Serin, M. Karakükçü, M. Çetin, “Successful delivery with ARA-C+thioguanine chemotherapy regimen in a pregnant patient with acute myeloblastic leukemia: A case report”, XXXI. National Hematology Congress, Poster 28, Belek-Antalya, 2004.
E40. Eser, B., Ramazan Coşkun, İ. Sarı, F. Altuntaş, M. Güven, M. Sungur, İ. S. Serin, M. Çetin, A. Ünal, “Postpartum plasma exchange in patients with type-1 HELLP syndrome: Does it reduce the mortality rate?”, XXXI. National Hematology Congress, Proceeding 70, Belek-Antalya, 2004.
E41. Cetin, M., I. Sarı, F. Altuntaş, B. Eser, K. Gundoğan, Y. Özkul, A. Unal, “Effects of different treatment modalities in chronic myelocytic leukemia on hematological and cytogenetic response”, XXX. National Hematology Congress, oral P49, Istanbul, 2003.
E42. Altuntaş, F., B. Eser, O Yıldız, İ Sarı, A Herek, S. Çiftçi, M. Bilgin, D. Eşel, M. Çetin, A. Ünal, “Catheter infections in patients undergoing peripheral stem cell transplantation”, XXX . National Hematology Congress, poster 161, Istanbul, 2003.
E43. Altuntaş, F., B. Eser, B. Kaplan, I. Sarı, O. Canöz, M. Özkan, Ş. Coşkun, S. Soyuer, M. Çetin, A. Ünal, “Early stage hodgkin’s disease: Single center experience”, XXX. National Hematology Congress, poster 214, Istanbul, 2003.
E44. Akalın, H., F. Altuntaş, S. Tekin, B. Eser, İ. Sarı, M. Çetin, A. Ünal, Y. Özkul, Chronic myeloid leukemia: Cytogenetic and molecular approaches, XXX. National Hematology Congress, Poster 88, Istanbul, 2003,.
E45. Sarı, İ., F. Altuntaş, B. Eser, M. Sipahioğlu, Ö. Canöz, M. Çetin, A. Ünal, A case of Waldenström macroglobulinemia with renal failure due to mesangioproliferative glomerulonephritis, XXX. National Hematology Congress, Poster 206, Istanbul, 2003.
Other publications (international articles published in peer-reviewed journals outside the scope of SCI, SCI-E):
G1. Dursunoglu D, Taskoylu O, Gür S, Sari I. Tirofiban-induced acute profound thrombocytopenia after primary angioplasty. Asian Cardiovasc Thorac Ann 2013;21(1):74-6.